Skip to main content
medic
helpline
Clinical Feed
Drug Index
News
Communities
Find Doctors
Hospitals
Log In
Join Free
Verified Professional Network
190+ Countries
HIPAA-Aware Platform
medic
helpline
Home
Clinical Feed
Drug Index
News
Communities
Find Doctors
Hospitals
Log In
Join Free
Home
Clinical Feed
Drug Index
News
Communities
Find Doctors
Hospitals
Rezpegaldesleukin (REZOLVE-AD) phase 2b: 16-week induction study of moderate-to-severe atopic derm | Clinical Feed | MedicHelpline